UCLA scientists have identified a molecule called PP405 that can reactivate dormant hair follicles, showing promising results in initial human trials. The treatment, backed by Google Ventures through Pelage Pharmaceuticals with $16.4 million in funding, aims to combat pattern hair loss that affects over half of men and one-fourth of women by age 50.
https://newsroom.ucla.edu/magazine/baldness-cure-pp405-molecule-breakthrough-treatment
via https://hnrss.org/newest?points=100, https://hnrss.org/newest?comments=100